跳至主要内容
临床试验/CTRI/2025/03/081759
CTRI/2025/03/081759尚未招募2/3 期

A prospective randomised study comparing the efficacy of 0.25 % bupivacaine and 0.25% levobupivacaine in pectoral nerve type 2 block for postoperative pain relief in patients undergoing elective modified radical mastectomy

Department of anaesthesiology1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2025年3月27日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
70
试验地点
1
主要终点
comparing the efficacy of 0.25% bupivacaine and 0.25% levobupivacaine in Carcinoma breast surgeries using PEC 2 block and the duration of postoperative analgesia

研究概览

简要总结

This study is a prospective randomised study comparing the efficacy of 0.25% bupivacaine and 0.25% levobupivacaine in PEC 2 block for postoperative pain relief in patients undergoing elective modified radical mastectomy surgery and to study the duration of postoperative analgesia

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
Female

入选标准

  • All patients of ASA grade I and grade II patients between 18 to 65yrs.

排除标准

  • 1]patient refusal to the procedure 2]any contraindications for regional anaesthesia technique like infection at the site of injection 3]coagulation disorder 4]drug allergy 5]history of other cancer 6]history of previous breast surgery 7]ASA grade IV 8]respiratory disease, cardiac disease and renal disease 9]having chemotherapy or radiotherapy in recent 8 weeks.

结局指标

主要结局

comparing the efficacy of 0.25% bupivacaine and 0.25% levobupivacaine in Carcinoma breast surgeries using PEC 2 block and the duration of postoperative analgesia

时间窗: 24 hours

次要结局

  • total rescue analgesia required in the first 24hrs(24hrs)

研究者

发起方
Department of anaesthesiology
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Radhika G S

Mysore medical college and research institute

研究点 (1)

Loading locations...

相似试验